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Results: 2854 patients treated with heparins were included. The risk of
major bleeding or transfusion (3.0% vs. 7.0%) and in-hospital death (3.2% vs
9.2%) was lower with LMWH compared with UFH, a difference that persisted
after multivariate adjustment (OR=0.51, 95% CI: 0.34-0.76 and OR=0.53,
95% CI: 0.37-0.76, respectively). Three-year survival and stroke and reinfarc-
tion-free survival were also higher with LMWH compared with UFH
(adjusted HR =0.73, 95% CI: 0.61-0.86 and HR =0.73, 95% CI: 0.62-0.85,
respectively). In two cohorts of patients matched on a propensity score for get-
ting LMWH and with similar baseline characteristics (834 patients per group),
major bleeding and transfusion were lower while three-year survival was sig-
nicantly higher in patients receiving LMWH.
Conclusion: The present data suggest that the use of LMWH in AMI
patients may have a better benefit/risk profile than UFH with in terms of
bleeding, need for transfusion, and long term survival.
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Background: Predictors of long-term outcome in optimally-treated
patients after AMI have not been extensively studied.
Aim: We assessed 3-year survival in a population of 3,262 patients from
the FAST-MI registry who were discharged alive after the acute episode.
Results: At hospital discharge, 1586 patients (49%) received optimal medical
treatment (OMT: antiplatelet + beta-blocker + statin + ACE-I or ARB agents).
Patients receiving OMT were younger (64±13 vs 69±14 years, p<0.001), had a
lower GRACE risk score (141 ±33 vs 151±36, p<0.001)and had more use of PCI
during index hospitalization (75% vs 56%,p<0.001). Three-year survival was 88%
in patients with OMT versus 77.5% in patients without (p<0.001). Cox multivar-
iate analysis was used to determine predictors of 3-year mortality and covariates
included age, sex, risk factors, comorbidities, type of AMI, CAD extent, use of
PCI, use of CABG, in-hospital complications, and other discharge medications.
Overall, adjusted HR for 3-year death was 0.82 (0.68-1.00), p=0.048, for patients
receiving OMT, confirming the benefit of comprehensive therapy beyond each of
its individual components. In the 1586 patients receiving OMT at discharge, inde-
pendent predictors of long-term death were age ≥75 years [HR 1.93 (1.03-3.64)];
AMI type and severity [STEMI vs NSTEMI: HR 0.64 (0.44-0.93); GRACE score:
HR 1.01 (1.00-1.01); LVEF< 40%: HR 2.03 (1.31-3.16); 3-vessel CAD: HR 2.12
(1.28-3.52)]; previous CV history [stroke: HR 1.91 (1.29-2.83), CHF: HR 1.79
(1.11-2.88)]; management with an invasive strategy [HR 0.31 (0.17-0.56)], and
associated conditions [history of diabetes HR 1.79 (1.28-2.49); history of cancer
HR 2.76 (1.75-4.33); current smoking at the time of AMI HR 1.88 (1.20-2.94)].
Conclusion: In patients receiving OMT after AMI, early invasive manage-
ment remains a significant predictor of improved survival, while associated
non cardiac conditions (and in particular cancer, diabetes, previous TIA or
stroke, and smoking) are major determinants of higher long-term mortality.
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Purpose: Death rate of acute coronary syndromes has decreased for more
than 50 years. Out-of-hospital mortality remains high despite improvements in
acute coronary syndrome’s care.
Aims: To evaluate the importance of out-of-hospital mortality and the
main determinants of in-hospital and one-year mortality in France.
Methods: Analyses were based on data from the French MONICA popu-
lation-based registry including exhaustively all acute coronary syndromes
occurring in people aged 35-74 during the year 2006 in 3 geographic areas.
First we evaluated out-of-hospital mortality. Then analyses were performed
through Cox models on incident ACS reaching the hospital alive in order to
determine main factors explaining the one-year mortality. Number of attribut-
able deaths was assessed for variables of interest.
Results: After a one-year follow-up, case-fatality was 29.3% for incident
events (n=2547) with 70.3% of out-of-hospital deaths and 21.1% occurring in
the 28 days following the event. The number of attributable deaths related to
3 situations with a strong impact identified from multivariate analyses (out-of-
hospital life-and-death emergency, hospitalization before ACS occurrence,
and lack of coronary angiography) was 130 (59% of deaths occurring after
reaching the hospital) during the one-year follow-up. These sub-groups were
corresponding to patients with an important initial state of severity and not
benefiting from traditionally recommended treatments.
Conclusion: The major part of deaths after ACS occurs in the out-of-hos-
pital phase. Moreover, the major part of one-year mortality is associated with
a very poor prognosis before medicalization. This underlines the importance
of cardiovascular prevention, population education and better out-of-hospital
emergency management.
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Objectives: We assessed the impact of invasive strategy (IS) versus a
conservative strategy (CS) on in-hospital complications and three-year out-
comes in patients with Non-ST-Elevation Myocardial Infarction (NSTEMI)
from the FAST-MI registry.
Background: Results from randomized trials comparing IS and CS in
patients with NSTEMI are conflicting.
Methods: Of the 3,670 patients in the FAST-MI registry, which included
patients with acute myocardial infarction (within 48 hours) over a one-month
period in France at the end of 2005, 1,645 presented with NSTEMI.
Results: Of the 1,645 patients analyzed, 80% had an IS. Patients in the IS
group were younger (67±12 vs. 80±11 years), less often women (29% vs.
51%) and had a lower GRACE risk score (137±36 vs. 178±34) as compared
with patient treated with CS. In-hospital mortality and blood transfusions were
significantly more frequent in patients with CS as compared with IS (13.1 vs.
2.0%, 9.1 vs. 4.6%). Use of IS was associated with a significant reduction in
3-year mortality and cardiovascular death (17% vs. 60%, adjusted HR: 0.44;
95%CI: 0.35-0.55 and 8% vs. 36%, adjusted HR: 0.37; 95%CI: 0.27-0.50).
© Elsevier Masson SAS. All rights reserved.
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After propensity score matching (181 patients per group), 3-year survival was
significantly higher in patients treated with IS.
Conclusions: In a real-world setting of patients admitted with NSTEMI,
the use of IS during the initial hospital stay is an independent predictor of
improved 3-year survival, regardless of age.
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Objectives Coronary artery spasm is an important physiopathological
mechanism in some forms of myocardial ischemic disease. Increased levels of
inflammatory markers and mean platelet volume (MPV) are associated with
increased risk thromboembolism, but the relationship between these parame-
ters and coronary artery spasm is unclear.
Methods During coronary angiography, iv methylergometrin was injected
to 345 patients with chest pain and normal coronary angiograms to provoke
coronary artery spasm. Pts were divided into 2 groups according to results:
spasm group (60 pts) and non-spasm group (285 pts). We compared between
groups: 1) inflammatory markers including C-reactive protein (CRP), white
blood cells (WBC), polymorphonuclear neutrophils (PMN), monocytes (MO),
and lymphocytes (LY); 2) hemostasis markers including mean platelet volume
(MPV), platelet count, fibrinogen (FIB) and D-Dimers (DD); 3) traditional risk
factors for vascular disease, ie. hyperlipidemia, triglycerides (TG), total choles-
terol (TC), LDL and HDL cholesterol (LDL-C, HDL-C) and uric acid (UA).
Results Compared with females, more males with chest pain suffered spasm
during the provocation test (23.56% vs 11.11%, p<0.05). There was no significant
difference in serum levels of LDL-C, HDL-C, TG, TC, LY, MPV and FIB
between groups (p>0.05). Serum levels of CRP and blood counts of PMN and
MO were signicantly higher in the spasm group (P<0.05). Compared with
females, males had a higher frequency of a history of smoking (58.04% vs
46.78%, P<0.05). Logistic regression analysis showed that smoking, PMN and
MO counts were significantly and independently associated with coronary artery
spasm with odds ratios (OR) of 3.52 (1.79-6.90 95% CI, P=0.000), 1.21 (1.07-
1.46 95% CI, P=0.04) and 5.35 (1.37-21.07 95% CI, P=0.01), respectively.
Conclusions Inflammation may contribute to pathogenesis of coronary
artery spasm. Smoking, PMN count and MO count appear to be clinical risk
factors for coronary artery spasm. Conversely, spasm does not seem to be
associated with abnormalities in thrombogenesis.
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Aims: Recommendations on the use of antithrombotic agents, antihyperten-
sive drugs and statin for secondary prevention of coronary artery (CAD), isch-
emic cerebrovacular (CVD), and peripheral arterial (PAD) diseases are now well
established. However, there may be a gap between clinical practice and evi-
dence-based guidelines. We aimed to investigate the premorbid use of secondary
prevention medications in patients with recurrent cardiovascular events.
Methods and results: We prospectively recorded all patients with CVD and
CAD in Dijon, France from 2006 to 2010. Data about medical history and prior
use of treatments were collected. Mutivariate analyses were performed to identify
predictors of the use of medications in patients with previous cardiovascular dis-
ease. Among the 2126 patients included (1270 CVD and 856 CAD), 867 (40.8%)
had a history of cardiovascular diseases including 448 (51.7%) with prior CVD
only, 191 (22.0%) with prior CAD only, 68 (7.8%) with prior PAD only, and 160
(18.5%) with polyvascular disease. In these patients, 57.3% were on antithrom-
botic therapy, 61.2% were treated with antihypertensive drugs, 32.9% received
statins, and only 23.6% were on an optimal regimen, defined as the combination
of the three therapies. Compared with patients with previous CAD only, those
with previous CVD only were less likely to be receiving each of these treatments
or to receive an optimal regimen (OR=0.17, p<0.001).
Conclusion: This study highlighted the underuse of recommended sec-
ondary preventive therapies in current clinical practice. Underuse was partic-
ularly pronounced in patients with previous CVD. These findings may account
for the burden of recurrent events.
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Objective Platelet activation is present in atrial fibrillation (AF), but there is
some debate whether this is due to AF itself and/or to underlying cardiovascular
diseases. We aim to determine the association between a marker of platelet reac-
tivity (mean platelet volume (MPV)) and systemic inflammation (CRP) mea-
sured on admission, and new onset episode of AF in patients with MI.
Patients and methods Prospective cohort of 4994 consecutive patients
with AMI. Patients with paroxysmal or persistent AF were excluded.
Results 426 (8.5%) patients were diagnosed with a new onset of AF during
the in-hospital-stay (mean stay 3±2 days). These patients were older (75 vs 65,
p<0.001), predominantly male, and prevalence of hypertension and diabetes was
greater. Also less smoker were found among this group. Despite similar reper-
fusion strategies, clinical presentation with heart failure and increased heart rate
(HR) was more frequently found in patients with AF. Left ventricular ejection
fraction (LVEF) was significantly depressed in AF patients (47 vs. 55, p<0.001),
among with increased NT-proBNP, admission MPV (8.9 vs. 8.6, p<0.001) and
CRP (10.7 vs 5.7, p<0.001). Backward logistic regression analysis (model 1)
found that age [OR=1.04, 95%CI (1.031-1.050), p<0.001)], HR [OR=1.016,
95%CI (1.011-1.021), p<0.001)], LVEF [OR=0.979, 95%CI (0.970-0.987),
p<0.001)] and MPV [OR=1.182, 95%CI (1.064-1.312), p<0.001)] were inde-
pendent predictors of AF occurrence. A second backward regression analysis
(model 2= model 1+CRP) found that age [OR=1.036, 95%CI (1.026-1.046),
p<0.001)], HR [OR=1.013, 95%CI (1.008-1.018), p<0.001)], LVEF [OR=0.977,
95%CI (0.968-0.987), p<0.001)] and CRP [OR=1.003, 95%CI (1.001-1.005),
p=0.006)] were independent predictors of AF occurrence after MI.
Conclusions This study suggested that new onset of AF early after MI is
rather linked to inflammation induced by myocardial damage or the existing
atherosclerotic burden than platelet activation.
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